Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Urology
|
July 18, 2020
Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer
Luke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
Urologic Oncology
|
March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients
Jonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
The Journal of Urology
|
August 26, 2021
Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?
Cheyenne Williams, Michael Ahdoot, Michael A Daneshvar, et al.
The Journal of Urology
|
October 11, 2021
Reply by Authors
Cheyenne Williams, Michael Ahdoot, Michael A Daneshvar, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)
|
May 18, 2021
MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up
Sherif Mehralivand, Arvin K George, Anthony N Hoang, et al.
Journal of Translational Medicine
|
May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study
Yair Lotan, Satoshi Anai, Howard Kim, et al.
European Urology Oncology
|
April 19, 2021
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance
Luke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
BJU International
|
May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance
Jonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
The Journal of Urology
|
July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance
Alex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
The New England Journal of Medicine
|
March 5, 2020
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Michael Ahdoot, Andrew R Wilbur, Sarah E Reese, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Urology
|
July 18, 2020
Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer
Luke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
Urologic Oncology
|
March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients
Jonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
The Journal of Urology
|
August 26, 2021
Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?
Cheyenne Williams, Michael Ahdoot, Michael A Daneshvar, et al.
The Journal of Urology
|
October 11, 2021
Reply by Authors
Cheyenne Williams, Michael Ahdoot, Michael A Daneshvar, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)
|
May 18, 2021
MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up
Sherif Mehralivand, Arvin K George, Anthony N Hoang, et al.
Journal of Translational Medicine
|
May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study
Yair Lotan, Satoshi Anai, Howard Kim, et al.
European Urology Oncology
|
April 19, 2021
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance
Luke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
BJU International
|
May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance
Jonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
The Journal of Urology
|
July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance
Alex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
The New England Journal of Medicine
|
March 5, 2020
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Michael Ahdoot, Andrew R Wilbur, Sarah E Reese, et al.
Page
of 5